Evaluation of a Telehealth Intervention Combining Structured Self-Monitoring of Blood Glucose and Nurse Care Coordination Among People With Type 2 Diabetes Noninsulin-Treated
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus, Type 2
- Sponsor
- Sutter Health
- Enrollment
- 90
- Locations
- 1
- Primary Endpoint
- Hemoglobin A1c
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
Telehealth remote patient monitoring is a means of using communications technology - such as telephones, computers, and the Internet - to connect patients remotely with their healthcare team from their homes. The investigators hope to learn more about improving healthy behaviors and blood glucose among persons with diabetes using telehealth remote patient monitoring technology to connect directly with nurse care coordinators.
The purpose of this study is to evaluate a process for improving blood glucose and healthy behaviors among people with type 2 diabetes using telehealth remote patient monitoring technology with nurse care coordinators. Some of the people in this study will work with a nurse care coordinator who will review your blood glucose weekly and call you at home every month for 3 months, while some of the people in this study will simply receive their normal care. At the end of the study, every participant will be asked questions about how they feel about their health care.
Investigators
Deborah Greenwood
Diabetes Clinical Nurse Specialist
Sutter Health
Eligibility Criteria
Inclusion Criteria
- •Enrolled in diabetes disease management program
- •ages 30-70
- •HbA1c between 7.5% and 10.9% in the previous six months
- •an Internet or 3G connection and email address;
- •a working phone line (land line or cellular); and
- •ability to read and understand the English language.
Exclusion Criteria
- •taking insulin;
- •inability to independently engage in self-management behaviors (diagnosis of dementia, severe depression, schizophrenia, or cognitive impairment);
- •severe complications, which would preclude achieving an HbA1c goal of 7% including diagnosis of the following:
- •severe stroke;
- •heart failure;
- •end-stage renal disease;
- •kidney dialysis; and
- •legally blind.
Outcomes
Primary Outcomes
Hemoglobin A1c
Time Frame: Change from baseline to 6 months
Lab test
Secondary Outcomes
- Empowerment(Change from baseline to 3 months)
- Behavior Change(Change from baseline to 3 months)
- Knowledge(Change from baseline to 3 months)